Oligonucleotide therapies for nonalcoholic steatohepatitis

• প্রধান লেখক: Sixu Li (লেখক), Feng Xiong (লেখক), Songbo Zhang (লেখক), Jinghua Liu (লেখক), Guangping Gao (লেখক), Jun Xie (লেখক), Yi Wang (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Elsevier, 2024-06-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Nonalcoholic steatohepatitis (NASH) represents a severe disease subtype of nonalcoholic fatty liver disease (NAFLD) that is thought to be highly associated with systemic metabolic abnormalities. It is characterized by a series of substantial liver damage, including hepatocellular steatosis, inflamma...